Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease. (2022)
Attributed to:
Cellular and molecular insights into neurodegeneration mediated by the C9orf72 gene mutation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-064173
PubMed Identifier: 35798516
Publication URI: http://europepmc.org/abstract/MED/35798516
Type: Journal Article/Review
Volume: 12
Parent Publication: BMJ open
Issue: 7
ISSN: 2044-6055